0000914190-19-000328.txt : 20190821 0000914190-19-000328.hdr.sgml : 20190821 20190821163248 ACCESSION NUMBER: 0000914190-19-000328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190819 FILED AS OF DATE: 20190821 DATE AS OF CHANGE: 20190821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlow Brenda S. CENTRAL INDEX KEY: 0001443851 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 191043370 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-08-19 0000842023 BIO-TECHNE Corp TECH 0001443851 Furlow Brenda S. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 SVP - General Counsel Common Stock 2019-08-19 4 M 0 1759 A 3948 D Common Stock 2019-08-19 4 F 0 745 197.57 D 3203 D Stock Options (Right to Buy) 94.35 2021-08-12 Common Stock 9600 9600 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 10000 10000 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 5995 5995 D Restricted Stock Units 2019-08-19 4 M 0 1759 0 D Common Stock 1759 0 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 10857 10857 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 14476 14476 D Restricted Stock Units Common Stock 1724 1724 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 9503 9503 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 12670 12670 D Restricted Stock Units Common Stock 1374 1374 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 7339 7339 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 9786 9786 D Restricted Stock Units Common Stock 1969 1969 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 9968 9968 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 13290 13290 D Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Fully exercisable. On 8/19/2019, the Board of Directors certified vesting of 1,759 performance RSUs. Options to purchase 3,619 shares vest on each of 8/18/2017, 8/18/2018, 8/18/2019 and 8/18/2020. Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 3,167 shares vest on each of 8/9/2018 and 8/9/2019 and options to purchase 3,168 shares vest on each of 8/9/2020 and 8/9/2021. Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023. /s/ Anna Weispfenning as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed. 2019-08-21